John B. Green, Chief Financial Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 68,438 shares at $21.27 ($1.5M) on 2020-01-17, disclosed to the SEC on 2020-01-21.
Open-market sale of $1.5M DRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.26 | 20,469 | $435K | 29.9% |
| 2 | $21.26 | 20,469 | $435K | 29.9% |
| 3 | $21.27 | 27,500 | $585K | 40.2% |
| Total | $21.26 avg | 68,438 | $1.5M | 100% |
| Filing → |
| DRNA | SELL | 2019-11-27 | $312K | — | Filing → |
| DRNA | SELL | 2019-11-20 | $263K | — | Filing → |
| DRNA | SELL | 2019-11-15 | $71K | — | Filing → |